| View |
|
DR-XY40563
|
Linezolid
|
Zyvox
|
2mg/ mL (600mg/ 300mL)
|
Solution for Infusion (IV)
|
Antibacterial (Oxazolidinone)
|
Fresenius Kabi Norge
|
Norway
|
Automatic Renewal
|
11 February 2022
|
06 February 2027
|
| View |
|
DR-XY40572
|
Pyridoxine Hydrochloride (Vit.B6) + Thiamine Mononitrate (Vit.B1) + Cyanocobalamin (Vit.B12)
|
Biovid Forte
|
250mg/ 242.5mg/ 1mg
|
Film-Coated Tablet
|
Vitamins
|
Hovid Bhd
|
Malaysia
|
Automatic Renewal
|
14 October 2021
|
03 February 2027
|
| View |
|
DR-XY40573
|
Bicalutamide
|
Bicapros
|
50mg
|
Film-Coated Tablet
|
Anti-androgens
|
Laboratorios Richmond S.A.C.I.F.
|
Argentina
|
Automatic Renewal
|
09 December 2021
|
27 January 2027
|
| View |
|
DR-XY40576
|
Dobutamine (as Hydrochloride)
|
Imatim
|
250mg
|
Lyophilized Powder for Injection (IV)
|
Adrenergic & Dopaminergic Agent
|
Gufic Biosciences
|
India
|
Automatic Renewal
|
16 February 2022
|
27 January 2027
|
| View |
|
DR-XY40579
|
Levodopa + Benserazide (As Hydrochloride)
|
Madopar
|
200 mg/ 50 mg
|
Tablet
|
Antiparkinson Drug (Dopaminergic Agent)
|
Delpharm Milano S.r.L
|
italy
|
Initial (Variation)
|
25 August 2022
|
25 August 2027
|
| View |
|
DR-XY40581
|
Salbutamol (As Sulfate) + Guiafenesin
|
Guasal
|
1 mg/50 mg per 5mL
|
Syrup
|
Selective Beta-2-adrenoreceptor Agonist/Expectorant
|
Syndenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 December 2021
|
31 January 2027
|
| View |
|
DR-XY40588
|
Carvedilol
|
Betacard (reformulated)
|
6.25 mg
|
Tablet
|
Alpha and Beta Blocking Agent
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
30 June 2023
|
30 June 2028
|
| View |
|
DR-XY40589
|
Losartn Potassium + Hydrochlorothiazide
|
Anin 50 Plus
|
50mg/12.5mg
|
Film-Coated Tablet
|
-
|
Delta Pharma Limited
|
Bangladesh
|
Renewal
|
21 March 2022
|
12 July 2025
|
| View |
|
DR-XY40595
|
Montelukast (as Sodium)
|
Montiget
|
10mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
30 December 2021
|
01 February 2027
|
| View |
|
DR-XY40599
|
Ascorbic Acid (as Sodium Ascorbate) + Folic Acid + iron (as Ferrous Sulfate)
|
Ferovone
|
100mg (Equivalent to 112.49mg Sodium Ascorbate) 400mg, 63.23mg (Equivalent to 325mg ferrous Sulfate)
|
Capsule
|
Vitamins and Mineral
|
Marnets Pharma Corporation
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
19 January 2027
|
| View |
|
DR-XY40602
|
Kanamycin (As Sulfate)
|
Kanacin
|
1 g
|
Powder For Injection (IM)
|
Antituberculosis Medicines
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
30 December 2021
|
02 February 2027
|
| View |
|
DR-XY40606
|
Tamsulosin Hydrochloride
|
Tamsumax
|
400mcg
|
Sustained-Release Capsule
|
ALPHA-ADRENORECEPTOR ANTAGONIST
|
Hangzhou Conba Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
16 February 2022
|
03 February 2027
|
| View |
|
DR-XY40607
|
Tamsulosin Hydrochloride
|
Tamsumax
|
200mcg
|
Sustained-Release Capsule
|
ALPHA-ADRENORECEPTOR ANTAGONIST
|
Hangzhou Conba Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
16 February 2022
|
03 February 2027
|
| View |
|
DR-XY40608
|
Tacrolimus
|
Tacromax
|
1mg
|
Capsule
|
IMMUNOSUPPRESSANT (CALCINEURIN INHIBITOR)
|
Zhejiang Hisun Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
22 January 2022
|
03 February 2027
|
| View |
|
DR-XY40609
|
Bacillus clausii
|
Erceflora
|
2 billion/ 5 mL
|
Oral Suspension
|
Antidiarrheal of Microbial Origin
|
Sanofi-S.p.A.
|
Italy
|
Automatic Renewal
|
13 January 2022
|
03 February 2027
|
| View |
|
DR-XY40612
|
Oseltamivir (as Phospate)
|
Tamiflu
|
75 mg
|
Capsule
|
Antiviral (Neuraminidase Inhibitor)
|
Roche S.p.A.
|
Italy
|
Automatic Renewal
|
22 January 2022
|
06 February 2027
|
| View |
|
DR-XY40614
|
Ranitidine (as Hydrochloride)
|
Zantol
|
25mg/ mL (50mg/ 2mL)
|
Solution for Injection (IM/IV)
|
H2-Receptor Antagonist
|
Zhejiang Ruixin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
20 September 2021
|
08 September 2026
|
| View |
|
DR-XY40623
|
Amoxicillin (As Trihydrate)
|
Ambimox
|
500 mg
|
Capsule
|
-
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.
|
China
|
Renewal (Variation)
|
13 February 2020
|
13 February 2025
|
| View |
|
DR-XY40642
|
Carvedilol
|
Dilabloc
|
25 mg
|
Tablet
|
Beta Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 December 2021
|
14 February 2027
|
| View |
|
DR-XY40652
|
Hydralazine Hydrochloride
|
Aprezal
|
20 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Direct Vasodilators
|
Kwality Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal (Correction)
|
30 January 2022
|
16 February 2027
|